SCYNEXIS Stock

SCYNEXIS Net Tangible Assets

The Net Tangible Assets of SCYNEXIS (SCYX) as of Aug 8, 2026 is 55.08 M USD. In the previous year, Net Tangible Assets was 72.96 M USD — a change of -24.51% (lower).

Net Tangible Assets

55.08 MUSD

YoY

-24.51%

Last updated:

Net Tangible Assets of SCYNEXIS is 2026 55.08 M USD. Net Tangible Assets of SCYNEXIS was 2025 72.96 M USD. It decreases by -24.51% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Net Tangible Assets of SCYNEXIS is 55.08 M USD in 2026.

Net Tangible Assets of SCYNEXIS changed from 72.96 M USD to 55.08 M USD, representing a -24.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — SCYNEXIS

All Key Metrics — SCYNEXIS